AB0502 CELLULAR AND PROTEOMIC CHANGES FOLLOWING ADMINISTRATION OF PERESOLIMAB, IN A PHASE 2A TRIAL IN RHEUMATOID ARTHRITIS

Benschop R.,Tuttle J., Emery P., Preuss C., Daniels M., Chang C.Y., Yachi P., Nirula A.

Annals of the Rheumatic Diseases（2024）

Cited 0|Views0

Key words

Biomarkers,Clinical Trial

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined